Members' Business Motion · S7M-01394 · Session 7
Octopus Clinical Trial for Primary and Secondary Progressive Multiple Sclerosis
The motion
That the Parliament welcomes the recent interim results from the Octopus clinical trial for primary and secondary progressive Multiple Sclerosis (MS), which has indicated that alpha-lipoic acid has early promise as a potential treatment; notes that Octopus is designed to test potential treatments up to three times faster than traditional trials by using the multi-arm, multi-stage (MAMS) approach; understands that the trial is testing repurposed treatments and, at this stage, has tested metformin and alpha-lipoic acid; welcomes that alpha-lipoic acid will now continue to the next stage of the trial, which will see hundreds more people recruited; believes that Octopus demonstrates that an innovative approach to clinical trials is possible with MS and that this encouraging news is a step in the right direction to finding treatments to slow or stop progression of MS; anticipates that new treatments to be tested will be announced in early 2027 and that the final results of the alpha-lipoic stage of the trial will be available in 2029; considers this to be a positive development for people living with progressive MS, including in Paisley, who currently have limited treatment options, and wishes staff and participants well as the trial continues.
Signatures by party
20 MSPs besides the lodger · 7 from other partiesSNP 13Con 3Lab 2Reform 2
Party on the day each MSP signed. Signing a motion is voluntary and not whipped. Who signs whose motions
Vote
No recorded vote on this motion. Most motions are never debated, and many that are debated are agreed without a division. Vote records are published from 2011.
Supporters
20 MSPsSNP 13 Con 3 Lab 2 Reform 2
Show all 20 supporters by party
SNP 13
- Heather Anderson
- Colin Beattie
- Dawn Black
- Gary Bouse
- Patricia Gibson
- Clare Haughey
- Alex Kerr
- Fulton MacGregor
- Stuart McMillan
- Lloyd Melville
- Jack Middleton
- Collette Stevenson
- David Torrance
Con 3
Lab 2
Reform 2
Party shown is each supporter’s party when the motion was published.
In the Official Report
No contribution in the Official Report cites S7M-01394 by reference.